| | 851199-59-2 Basic information More.. |
| Product Name: | Linaclotide | | Synonyms: | Linaclotide;Linaelotide Acetate;Linaelotide;CY-14;Liclotide;L-Tyrosine, L-cysteinyl-L-cysteinyl-L-α-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (1→6),(2→10),(5→13)-tris(disulfide);Linaclotide USP/EP/BP;Rinalodipine Acetate | | CAS: | 851199-59-2 | | MF: | C59H79N15O21S6 | | MW: | 1526.75 | | EINECS: | 251-228-4 | | Mol File: | 851199-59-2.mol |  |
Use
In August 2012, the US FDA approved linaclotide (also referred to as MD-1100), a first-in-class, orally administered 14-amino acid peptide as a therapy for patients suffering from chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C).
- Linaclotide
-
- 2026-08-31
- CAS:851199-59-2
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Linaclotide
-
- 2026-08-31
- CAS:851199-59-2
- Min. Order: 1g
- Purity: 98%min
- Supply Ability: 100g
|
|
851199-59-2
Recommend Suppliers |
|